Centrient Pharmaceuticals
Neil Moorhouse has diverse work experience in various leadership and communication roles. Neil currently serves as a Board Member for the AMR Industry Alliance and as the Country President & Global Head of Communications & ESG at Centrient Pharmaceuticals. Previously, Neil worked as a partner consultant at Positive Momentum, a Certified B Corp®, and as the Vice President and Head of Integrated Communications at Signify. Neil also held positions as a corporate communications leader at WABCO, Group Director of Corporate Media Affairs at VEON, and Global Head of Communications at Sandoz. Before that, Neil worked in various global roles at RBS and ABN AMRO, focusing on communications. Earlier in their career, they served as a Bureau Chief at Dow Jones and as a Financial Analyst at EFG Hermes.
Neil Moorhouse completed their education with a Bachelor's degree in Medieval and Modern Languages and Literature at the University of Oxford from 1985 to 1989. Prior to that, from 1983 to 1985, they attended St John Rigby VIth Form College. Additionally, they completed their secondary education at Thornleigh Salesian College, Bolton from 1977 to 1983.
This person is not in any offices
Centrient Pharmaceuticals
2 followers
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs). We stand proudly at the centre of modern healthcare, as a maker of essential and life-saving medicines. With our commitment to Quality, Reliability and Sustainability at the heart of everything we do, our over 1,800 employees work continuously to meet our customers’ needs. We work towards a sustainable future by actively participating in the fight against antimicrobial resistance. Founded 150 years ago as the ‘Nederlandsche Gist- en Spiritusfabriek’, our company was known as Gist Brocades and more recently DSM Sinochem Pharmaceuticals. Headquartered in Rotterdam (Netherlands), we have production facilities and sales offices in China, India, the Netherlands, Spain, the United States and Mexico. Centrient Pharmaceuticals is owned by Bain Capital Private Equity, a leading global private investment firm.